Tri-Institutional MD PhD Program, Weill Cornell Medical College, New York, New York, USA
Weill Cornell Medicine Department of Pathology and Laboratory Medicine, New York, New York, USA.
BMJ Case Rep. 2020 Apr 14;13(4):e233860. doi: 10.1136/bcr-2019-233860.
In the era of highly active antiretroviral therapy (HAART), disseminated Kaposi sarcoma (KS) has become much rarer in the USA. We report a case of a 34-year-old man with KS of the skin, oropharynx, lung and rectum. Within the same lung nodule, we discovered significant burden of colesional in the context of a positive asymptomatic cryptococcal antigenemia, which was a previously unreported occurrence. The gold standard of treatment for KS continues to be HAART. The role of chemotherapy is still controversial. In addition, a cryptococcal antigen screen-and-treat approach with fluconazole is still not routinely recommended in the USA to prevent serious meningeal disease despite recent studies showing efficacy and applicability. We discuss both issues here and the outcome of our patient. We also present the patient's own unique perspective in dealing with the ramifications of these diagnoses.
在高效抗逆转录病毒治疗(HAART)时代,美国弥漫性卡波西肉瘤(KS)已变得罕见得多。我们报告了一例皮肤、口咽、肺和直肠 KS 的 34 岁男性患者。在同一肺结节中,我们发现了大量的 ,同时伴有无症状隐球菌抗原血症,这是以前未报道过的情况。KS 的标准治疗方法仍然是 HAART。化疗的作用仍然存在争议。此外,尽管最近的研究显示了其疗效和适用性,但美国仍不常规推荐使用氟康唑进行隐球菌抗原筛查和治疗,以预防严重的脑膜疾病。我们在这里讨论这两个问题以及我们患者的结果。我们还介绍了患者自己在处理这些诊断结果时的独特视角。